Detalhe da pesquisa
1.
Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent.
J Allergy Clin Immunol
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597862
2.
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.
J Allergy Clin Immunol
; 151(1): 192-201, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223848
3.
Real-world experience of pediatric patients treated with peanut (Arachis hypogaea) allergen powder-dnfp.
Ann Allergy Asthma Immunol
; 130(5): 649-656.e4, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738781
4.
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials.
Ann Allergy Asthma Immunol
; 129(6): 758-768.e4, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973655
5.
AR101 Oral Immunotherapy for Peanut Allergy.
N Engl J Med
; 379(21): 1991-2001, 2018 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449234
6.
The global burden of illness of peanut allergy: A comprehensive literature review.
Allergy
; 76(5): 1367-1384, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216994
7.
Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals.
Allergy Asthma Proc
; 42(4): 333-342, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34187625
8.
Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop.
J Allergy Clin Immunol
; 143(5): 1711-1726, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30731123
9.
Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2500 children with peanut allergy.
Ann Allergy Asthma Immunol
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479712
10.
Current management and use of oral immunotherapy in the United States for patients with peanut allergy.
Allergy Asthma Proc
; 40(4): 214-220, 2019 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31122310
11.
Exercise-induced bronchoconstriction update-2016.
J Allergy Clin Immunol
; 138(5): 1292-1295.e36, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27665489
12.
Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.
JAMA
; 318(18): 1798-1809, 2017 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29136445
13.
Functional Outcomes after Behavioral Treatment of Paradoxical Vocal Fold Motion in Adults.
Folia Phoniatr Logop
; 69(4): 154-168, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29393222
14.
Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.
Clin Exp Allergy
; 51(12): 1648-1652, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519110
15.
Extracellular vesicle microRNAs as predictors of response to omalizumab in chronic spontaneous urticaria.
Allergy
; 76(4): 1274-1277, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314187
16.
Practice parameter for the diagnosis and management of primary immunodeficiency.
J Allergy Clin Immunol
; 136(5): 1186-205.e1-78, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26371839
17.
Risk of physician burnout in the North American allergist-immunologist workforce: A report from the American College of Allergy, Asthma and Immunology Physician Wellness Taskforce.
Ann Allergy Asthma Immunol
; 125(3): 235-243, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32544532
18.
Validation of an ICD-9-based claims algorithm for identifying patients with chronic idiopathic/spontaneous urticaria.
Ann Allergy Asthma Immunol
; 114(5): 393-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25771155
19.
The diagnosis and management of acute and chronic urticaria: 2014 update.
J Allergy Clin Immunol
; 133(5): 1270-7, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24766875
20.
Food allergy: a practice parameter update-2014.
J Allergy Clin Immunol
; 134(5): 1016-25.e43, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25174862